找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

(版塊PHARMACOLOGY & PHARMACY(藥理學(xué)與藥學(xué))版塊期刊總數(shù):274)
新窗
投票 SCIE期刊SAUDI PHARMACEUTICAL JOURNAL 2024/2025影響因子:3.124 (SAUDI PHARM J) (1319-0164). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Sc  ...234
Total Citations:6152; 2023 JIF:3.124; JIFRank: 136/354 ; Rank-JIF: 136; Number-of-JIF:354; 5 Year JIF:3.958; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.9; Immediacy Index:0.7; Immediacy Index-dealt:0.778; 2023 JCI:1; JCI Rank: 81/354 ; Total Articles:306; JCI Quartile:Q1; JCI Percentile:77.26; Eigenfactor:0.004; Normalized Eigenfactor:0.911; Article Influence Score:0.573; JIF Percentile:61.7; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:334; % of Articles in Citable items:0.9162; Cited Half-Life:5.2; Citing Half-Life:6.9; % of OA Gold:0.9577; Publisher name:EMERALD GROUP PUBLISHING LTD; Publisher address:Floor 5, Northspring 21-23 We
投票 SCIE期刊Pharmacogenomics & Personalized Medicine 2024/2025影響因子:1.859 (PHARMACOGEN PERS MED) (NULL). (PHARMACOLOGY & PHARM  ...234
Total Citations:984; 2023 JIF:1.859; JIFRank: 240/354 ; Rank-JIF: 240; Number-of-JIF:354; 5 Year JIF:1.924; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.8; Immediacy Index:0.4; Immediacy Index-dealt:0.494; 2023 JCI:0.56; JCI Rank: 215/354 ; Total Articles:80; JCI Quartile:Q3; JCI Percentile:39.41; Eigenfactor:0.001; Normalized Eigenfactor:0.291; Article Influence Score:0.448; JIF Percentile:32.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:93; % of Articles in Citable items:0.8602; Cited Half-Life:3.3; Citing Half-Life:6.4; % of OA Gold:0.9846; Publisher name:MICROBIOL RES FOUNDATION; Publisher address:JAPAN ACAD SOC CENTER BLDG 4-16
投票 SCIE期刊Pharmacological Reports 2024/2025影響因子:3.631 (PHARMACOL REP) (1734-1140). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Science  ...234
Total Citations:5868; 2023 JIF:3.631; JIFRank: 94/354 ; Rank-JIF: 94; Number-of-JIF:354; 5 Year JIF:3.238; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.6; Immediacy Index:0.9; Immediacy Index-dealt:0.985; 2023 JCI:0.91; JCI Rank: 98/354 ; Total Articles:76; JCI Quartile:Q2; JCI Percentile:72.46; Eigenfactor:0.004; Normalized Eigenfactor:0.779; Article Influence Score:0.581; JIF Percentile:73.6; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:114; % of Articles in Citable items:0.6667; Cited Half-Life:7; Citing Half-Life:7.5; % of OA Gold:0.4282; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MI
投票 SCIE期刊DARU-Journal of Pharmaceutical Sciences 2024/2025影響因子:2.544 (DARU) (NULL). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Scien  ...234
Total Citations:2211; 2023 JIF:2.544; JIFRank: 180/354 ; Rank-JIF: 180; Number-of-JIF:354; 5 Year JIF:4.209; 5 Year JIF Quartile:Q1; JIF Without Self Cites:2.5; Immediacy Index:0.4; Immediacy Index-dealt:0.444; 2023 JCI:0.85; JCI Rank: 112/354 ; Total Articles:35; JCI Quartile:Q2; JCI Percentile:68.5; Eigenfactor:0.001; Normalized Eigenfactor:0.288; Article Influence Score:0.689; JIF Percentile:49.3; JIF Quartile:Q3; AIS Quartile:Q2; Citable Items:42; % of Articles in Citable items:0.8333; Cited Half-Life:7.5; Citing Half-Life:6.5; % of OA Gold:0.0667; Publisher name:WILEY-V C H VERLAG GMBH; Publisher address:POSTFACH 101161, WEINHEIM, GERMAN
投票 SCIE期刊NATURE REVIEWS DRUG DISCOVERY 2024/2025影響因子:122.748 (NAT REV DRUG DISCOV) (1474-1776). (PHARMACOLOGY & PHARMACY)(  ...234
Total Citations:48152; 2023 JIF:122.748; JIFRank: 1/354 ; Rank-JIF: 1; Number-of-JIF:354; 5 Year JIF:114.926; 5 Year JIF Quartile:Q1; JIF Without Self Cites:122.2; Immediacy Index:14.2; Immediacy Index-dealt:14.251; 2023 JCI:13.41; JCI Rank: 1/354 ; Total Articles:7; JCI Quartile:Q1; JCI Percentile:99.86; Eigenfactor:0.058; Normalized Eigenfactor:12.658; Article Influence Score:36.972; JIF Percentile:99.9; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:37; % of Articles in Citable items:0.1892; Cited Half-Life:6.6; Citing Half-Life:4.9; % of OA Gold:0.0991; Publisher name:AMER CHEMICAL SOC; Publisher address:1155 16TH ST, NW, WASHINGTON, USA
投票 SCIE期刊INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES 2024/2025影響因子:0.437 (INDIAN J PHARM SCI) (0250-474X). (PHARMACOLOGY & P  ...234
Total Citations:3350; 2023 JIF:0.437; JIFRank: 335/354 ; Rank-JIF: 335; Number-of-JIF:354; 5 Year JIF:0.694; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.4; Immediacy Index:<0.1; Immediacy Index-dealt:0.009; 2023 JCI:0.11; JCI Rank: 337/354 ; Total Articles:388; JCI Quartile:Q4; JCI Percentile:4.94; Eigenfactor:0.001; Normalized Eigenfactor:0.219; Article Influence Score:0.089; JIF Percentile:5.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:414; % of Articles in Citable items:0.9372; Cited Half-Life:11.3; Citing Half-Life:6.5; % of OA Gold:0.2351; Publisher name:SPRINGER INT PUBL AG; Publisher address:GEWERBESTRASSE 11, CHAM, SWITZERL
投票 SCIE期刊International Journal of Nanomedicine 2024/2025影響因子:6.691 (INT J NANOMED) (1178-2013). (PHARMACOLOGY & PHARMACY)(  ...234
Total Citations:39713; 2023 JIF:6.691; JIFRank: 20/354 ; Rank-JIF: 20; Number-of-JIF:354; 5 Year JIF:7.576; 5 Year JIF Quartile:Q1; JIF Without Self Cites:6.4; Immediacy Index:1.1; Immediacy Index-dealt:1.192; 2023 JCI:1.29; JCI Rank: 43/354 ; Total Articles:336; JCI Quartile:Q1; JCI Percentile:87.99; Eigenfactor:0.025; Normalized Eigenfactor:5.365; Article Influence Score:1.065; JIF Percentile:94.5; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:434; % of Articles in Citable items:0.7742; Cited Half-Life:5.6; Citing Half-Life:5.1; % of OA Gold:0.9845; Publisher name:FEDERAL RESERVE BANK ST LOUIS; Publisher address:BOX 442, ST LOUIS, USA, MO
投票 SCIE期刊Pakistan Journal of Pharmaceutical Sciences 2024/2025影響因子:0.754 (PAK J PHARM SCI) (1011-601X). (PHARMACOLOGY & PH  ...234
Total Citations:3110; 2023 JIF:0.754; JIFRank: 317/354 ; Rank-JIF: 317; Number-of-JIF:354; 5 Year JIF:0.833; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.7; Immediacy Index:0.1; Immediacy Index-dealt:0.138; 2023 JCI:0.21; JCI Rank: 315/354 ; Total Articles:226; JCI Quartile:Q4; JCI Percentile:11.16; Eigenfactor:0.002; Normalized Eigenfactor:0.353; Article Influence Score:0.114; JIF Percentile:10.6; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:226; % of Articles in Citable items:1; Cited Half-Life:6.4; Citing Half-Life:5.7; % of OA Gold:0; Publisher name:SPRINGER; Publisher address:VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS, 3311 GZ
投票 SCIE期刊JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2024/2025影響因子:3.987 (J ANTIMICROB CHEMOTH) (0305-7453). (PHARMACOLOGY & PHA  ...234
Total Citations:33199; 2023 JIF:3.987; JIFRank: 85/354 ; Rank-JIF: 85; Number-of-JIF:354; 5 Year JIF:4.647; 5 Year JIF Quartile:Q1; JIF Without Self Cites:3.6; Immediacy Index:0.9; Immediacy Index-dealt:0.915; 2023 JCI:1.11; JCI Rank: 67/354 ; Total Articles:336; JCI Quartile:Q1; JCI Percentile:79.81; Eigenfactor:0.026; Normalized Eigenfactor:5.768; Article Influence Score:1.324; JIF Percentile:65.5; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:364; % of Articles in Citable items:0.9231; Cited Half-Life:8.8; Citing Half-Life:6.1; % of OA Gold:0.2982; Publisher name:TAYLOR & FRANCIS INC; Publisher address:530 WALNUT STREET, STE 850, PHILADE
投票 SCIE期刊FUNDAMENTAL & CLINICAL PHARMACOLOGY 2024/2025影響因子:2.172 (FUND CLIN PHARMACOL) (0767-3981). (PHARMACOLOGY & PHARMA  ...234
Total Citations:2834; 2023 JIF:2.172; JIFRank: 210/354 ; Rank-JIF: 210; Number-of-JIF:354; 5 Year JIF:2.314; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.8; Immediacy Index:0.6; Immediacy Index-dealt:0.688; 2023 JCI:0.67; JCI Rank: 171/354 ; Total Articles:69; JCI Quartile:Q2; JCI Percentile:51.84; Eigenfactor:0.002; Normalized Eigenfactor:0.36; Article Influence Score:0.447; JIF Percentile:40.8; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:97; % of Articles in Citable items:0.7113; Cited Half-Life:8.8; Citing Half-Life:7.5; % of OA Gold:0.0775; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 SCIE期刊CURRENT PHARMACEUTICAL DESIGN 2024/2025影響因子:2.626 (CURR PHARM DESIGN) (1381-6128). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與  ...234
Total Citations:19484; 2023 JIF:2.626; JIFRank: 173/354 ; Rank-JIF: 173; Number-of-JIF:354; 5 Year JIF:3.115; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.5; Immediacy Index:0.7; Immediacy Index-dealt:0.782; 2023 JCI:0.48; JCI Rank: 247/354 ; Total Articles:99; JCI Quartile:Q3; JCI Percentile:30.37; Eigenfactor:0.009; Normalized Eigenfactor:1.991; Article Influence Score:0.528; JIF Percentile:51.3; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:276; % of Articles in Citable items:0.3587; Cited Half-Life:8.4; Citing Half-Life:6.9; % of OA Gold:0.0134; Publisher name:ASSOC CHAMP PENAL-PENAL FIELD; Publisher address:ASSOC CHAMP PENAL-PENAL
投票 SCIE期刊CHEMICO-BIOLOGICAL INTERACTIONS 2024/2025影響因子:4.752 (CHEM-BIOL INTERACT) (0009-2797). (PHARMACOLOGY & PHARMACY)(藥  ...234
Total Citations:17009; 2023 JIF:4.752; JIFRank: 55/354 ; Rank-JIF: 55; Number-of-JIF:354; 5 Year JIF:4.698; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.6; Immediacy Index:1; Immediacy Index-dealt:1.157; 2023 JCI:1.16; JCI Rank: 59/354 ; Total Articles:318; JCI Quartile:Q1; JCI Percentile:83.47; Eigenfactor:0.01; Normalized Eigenfactor:2.279; Article Influence Score:0.773; JIF Percentile:84.6; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:364; % of Articles in Citable items:0.8736; Cited Half-Life:6.6; Citing Half-Life:7.1; % of OA Gold:0.117; Publisher name:AIP PUBLISHING; Publisher address:1305 WALT WHITMAN RD, STE 300, MELVILLE, USA,
投票 SCIE期刊FOOD AND DRUG LAW JOURNAL 2024/2025影響因子:0.378 (FOOD DRUG LAW J) (1064-590X). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Sci  ...234
Total Citations:182; 2023 JIF:0.378; JIFRank: 344/354 ; Rank-JIF: 344; Number-of-JIF:354; 5 Year JIF:0.303; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.2; Immediacy Index:<0.1; Immediacy Index-dealt:0.054; 2023 JCI:0.1; JCI Rank: 341/354 ; Total Articles:14; JCI Quartile:Q4; JCI Percentile:15.32; Eigenfactor:0; Normalized Eigenfactor:0.022; Article Influence Score:0.125; JIF Percentile:36.7; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:15; % of Articles in Citable items:0.9333; Cited Half-Life:13.2; Citing Half-Life:9.6; % of OA Gold:0; Publisher name:BENTHAM SCIENCE PUBL LTD; Publisher address:EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZON
投票 SCIE期刊Journal of Pharmaceutical Investigation 2024/2025影響因子:5.377 (J PHARM INVEST) (2093-5552). (PHARMACOLOGY & PHARMAC  ...234
Total Citations:1721; 2023 JIF:5.377; JIFRank: 34/354 ; Rank-JIF: 34; Number-of-JIF:354; 5 Year JIF:NULL; 5 Year JIF Quartile:NULL; JIF Without Self Cites:4.9; Immediacy Index:0.5; Immediacy Index-dealt:0.545; 2023 JCI:1.1; JCI Rank: 68/354 ; Total Articles:25; JCI Quartile:Q1; JCI Percentile:80.93; Eigenfactor:0.001; Normalized Eigenfactor:0.283; Article Influence Score:0.419; JIF Percentile:90.5; JIF Quartile:Q1; AIS Quartile:NULL; Citable Items:42; % of Articles in Citable items:0.5952; Cited Half-Life:4.2; Citing Half-Life:7.2; % of OA Gold:0.0467; Publisher name:SAGE PUBLICATIONS LTD; Publisher address:1 OLIVERS YARD, 55 CITY ROAD, LONDO
投票 SCIE期刊REGULATORY TOXICOLOGY AND PHARMACOLOGY 2024/2025影響因子:3.154 (REGUL TOXICOL PHARM) (0273-2300). (PHARMACOLOGY & PHA  ...234
Total Citations:9087; 2023 JIF:3.154; JIFRank: 136/354 ; Rank-JIF: 136; Number-of-JIF:354; 5 Year JIF:3.174; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.7; Immediacy Index:0.9; Immediacy Index-dealt:0.921; 2023 JCI:1.16; JCI Rank: 59/354 ; Total Articles:135; JCI Quartile:Q1; JCI Percentile:83.47; Eigenfactor:0.005; Normalized Eigenfactor:1.041; Article Influence Score:0.584; JIF Percentile:61.7; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:143; % of Articles in Citable items:0.9441; Cited Half-Life:7.9; Citing Half-Life:8; % of OA Gold:0.4809; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 SCIE期刊MOLECULAR PHARMACEUTICS 2024/2025影響因子:4.515 (MOL PHARMACEUT) (1543-8384). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Scienc  ...234
Total Citations:22661; 2023 JIF:4.515; JIFRank: 60/354 ; Rank-JIF: 60; Number-of-JIF:354; 5 Year JIF:4.677; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.2; Immediacy Index:1; Immediacy Index-dealt:1.125; 2023 JCI:1.22; JCI Rank: 56/354 ; Total Articles:414; JCI Quartile:Q1; JCI Percentile:84.32; Eigenfactor:0.015; Normalized Eigenfactor:3.284; Article Influence Score:0.817; JIF Percentile:83.2; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:460; % of Articles in Citable items:0.9; Cited Half-Life:6.4; Citing Half-Life:7; % of OA Gold:0.1279; Publisher name:KOREAN AUDIOLOGICAL SOC; Publisher address:DEPT OTORHINOLARY-HEAD&NECK SURG, SEOUL
投票 SCIE期刊EXPERT OPINION ON THERAPEUTIC PATENTS 2024/2025影響因子:5.474 (EXPERT OPIN THER PAT) (1354-3776). (PHARMACOLOGY & PHA  ...234
Total Citations:4249; 2023 JIF:5.474; JIFRank: 32/354 ; Rank-JIF: 32; Number-of-JIF:354; 5 Year JIF:6.459; 5 Year JIF Quartile:Q1; JIF Without Self Cites:5.3; Immediacy Index:1.5; Immediacy Index-dealt:1.582; 2023 JCI:0.85; JCI Rank: 112/354 ; Total Articles:6; JCI Quartile:Q2; JCI Percentile:68.5; Eigenfactor:0.003; Normalized Eigenfactor:0.685; Article Influence Score:1.253; JIF Percentile:91.1; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:54; % of Articles in Citable items:0.1111; Cited Half-Life:6.3; Citing Half-Life:5.3; % of OA Gold:0.0414; Publisher name:SAGE PUBLICATIONS LTD; Publisher address:1 OLIVERS YARD, 55 CITY ROAD, LONDON,
投票 SCIE期刊JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 2024/2025影響因子:3.144 (J PHARMACOL EXP THER) (0022-3565). (PH  ...234
Total Citations:21598; 2023 JIF:3.144; JIFRank: 126/354 ; Rank-JIF: 126; Number-of-JIF:354; 5 Year JIF:3.346; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.9; Immediacy Index:2.4; Immediacy Index-dealt:2.464; 2023 JCI:1; JCI Rank: 81/354 ; Total Articles:102; JCI Quartile:Q1; JCI Percentile:77.26; Eigenfactor:0.006; Normalized Eigenfactor:1.326; Article Influence Score:0.824; JIF Percentile:64.5; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:121; % of Articles in Citable items:0.843; Cited Half-Life:16.9; Citing Half-Life:8.2; % of OA Gold:0.2568; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, Unite
投票 SCIE期刊PLANTA MEDICA 2024/2025影響因子:2.111 (PLANTA MED) (0032-0943). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Science Citation Ind  ...234
Total Citations:13284; 2023 JIF:2.111; JIFRank: 210/354 ; Rank-JIF: 210; Number-of-JIF:354; 5 Year JIF:2.856; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2; Immediacy Index:0.5; Immediacy Index-dealt:0.549; 2023 JCI:0.59; JCI Rank: 203/354 ; Total Articles:74; JCI Quartile:Q3; JCI Percentile:47.67; Eigenfactor:0.002; Normalized Eigenfactor:0.53; Article Influence Score:0.435; JIF Percentile:54.7; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:85; % of Articles in Citable items:0.8706; Cited Half-Life:15.1; Citing Half-Life:7.8; % of OA Gold:0.0707; Publisher name:ASCE-AMER SOC CIVIL ENGINEERS; Publisher address:1801 ALEXANDER BELL DR, RES
投票 SCIE期刊CLINICAL THERAPEUTICS 2024/2025影響因子:3.207 (CLIN THER) (0149-2918). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Science Citat  ...234
Total Citations:8387; 2023 JIF:3.207; JIFRank: 124/354 ; Rank-JIF: 124; Number-of-JIF:354; 5 Year JIF:3.161; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.2; Immediacy Index:1; Immediacy Index-dealt:1.135; 2023 JCI:0.73; JCI Rank: 154/354 ; Total Articles:83; JCI Quartile:Q2; JCI Percentile:56.64; Eigenfactor:0.006; Normalized Eigenfactor:1.341; Article Influence Score:0.862; JIF Percentile:65.1; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:135; % of Articles in Citable items:0.6148; Cited Half-Life:8.5; Citing Half-Life:6.1; % of OA Gold:0.2713; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, Unite
下一頁 »
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-25 12:00
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
返回頂部 返回版塊
翁牛特旗| 云林县| 临安市| 麟游县| 海宁市| 保定市| 马公市| 五家渠市| 宿迁市| 长寿区| 绥德县| 天门市| 哈尔滨市| 安国市| 车致| 安康市| 庐江县| 塘沽区| 阳信县| 察雅县| 浠水县| 威宁| 定陶县| 荆门市| 太和县| 弋阳县| 天柱县| 锡林郭勒盟| 东阳市| 忻城县| 锦州市| 孝感市| 彭州市| 临西县| 黄骅市| 镇江市| 丰城市| 古蔺县| 易门县| 伊吾县| 武强县|